EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Esculetin Improves LPS/D-GalN Induced Acute Liver Injury Through AMPK/SIRT1/PGC-1α Signaling Pathway

Haoyang Dai, Qinqin Zhang, Pei Chen, Suiqing Chen

Antioxidants · 21.05.2026 · 15 (5) · 652

DOI: 10.3390/antiox15050652 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antioxidants, online erschienen am 21.05.2026. Verfasst von Haoyang Dai und 3 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Henan University of Chinese Medicine, 156 Jinshui East Road, Zhengzhou 450046, China. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Program of Henan Provincial Drug Administration, the Major Science and Technology Project in Henan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The pathogenesis of acute liver injury (ALI) involves the loss of hepatic detoxification function, massive death of liver parenchymal cells within a short period, and excessive inflammatory responses. Studies have shown that Esculetin (Esc) possesses potent anti-inflammatory, antioxidant, and anti-tumor properties. In this study, we investigate whether Esc has a protective effect against ALI in mice and its potential mechanism. Esculetin markedly decreased ROS, MitoSOX, and apoptosis levels in AML12 cells and restored MMP. H&E staining demonstrated that Esc alleviated hepatic histopathological injury, and its intervention reduced serum ALT and AST levels. Moreover, Esc diminished ROS and apoptosis levels in the liver. Hepatic proteomic profiling identified the AMPK signaling pathway. Esc reduced the protein levels of p-AMPK/AMPK, PGC-1α, p-SIRT1/SIRT1, and BAX and upregulated the levels of Bcl-2 in liver tissue. Concomitantly, we added inhibitor Compound C (CC) to the AML12 cells to assess whether Esc acted through the AMPK pathway. The results showed that CC exacerbated the degree of liver injury, whereas Esc was able to reverse these phenomena, thus exerting an anti-liver injury effect. These findings provide mechanistic insights into the protective effects of Esc against ALI and support its potential as a therapeutic candidate for ALI.

Schlagwörter

Stichwörter der Autor:innen

AMPK/SIRT1/PGC-1αacute liver injuryapoptosisesculetinmitochondrial functionoxidative stress

Autor:innen und Institutionen

  • College of Pharmacy, Henan University of Chinese Medicine, 156 Jinshui East Road, Zhengzhou 450046, China.
  • Henan Key Laboratory of Chinese Medicine Resources and Chemistry, 156 Jinshui East Road, Zhengzhou 450046, China.
  • Collaborative Innovation Center of Research and Development on the Whole Industry Chain of Yu-Yao, Zhengzhou 450046, China.

Förderung

  • Science and Technology Program of Henan Provincial Drug Administration
  • the Major Science and Technology Project in Henan Province

Zitieren

APA

Dai, H., Zhang, Q., Chen, P., & Chen, S. (2026). Esculetin Improves LPS/D-GalN Induced Acute Liver Injury Through AMPK/SIRT1/PGC-1α Signaling Pathway. Antioxidants, 15(5), 652. https://doi.org/10.3390/antiox15050652

Vancouver

Dai H, Zhang Q, Chen P, Chen S. Esculetin Improves LPS/D-GalN Induced Acute Liver Injury Through AMPK/SIRT1/PGC-1α Signaling Pathway. Antioxidants. 2026;15(5):652. doi:10.3390/antiox15050652

BibTeX
@article{Dai2026,
  author = {Dai, Haoyang and Zhang, Qinqin and Chen, Pei and Chen, Suiqing},
  title = {Esculetin Improves LPS/D-GalN Induced Acute Liver Injury Through AMPK/SIRT1/PGC-1α Signaling Pathway},
  journal = {Antioxidants},
  year = {2026},
  volume = {15},
  number = {5},
  pages = {652},
  doi = {10.3390/antiox15050652}
}
Kostenlos starten →